Lucid Diagnostics Inc.
LUCDCIK 0001799011
Revenue (TTM)
$4.37M
+79.0% YoY
Q1 May 2026
Net Income (TTM)
−$55.65M
−27.4% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.95
+16.7% YoY
Q1 May 2026
Gross Margin
8.6%
Q1 May 2026
Operating Margin
-1,091.5%
Q1 May 2026
Net Margin
-1,272.4%
Q1 May 2026
Free Cash Flow (TTM)
−$44.77M
Q1 May 2026
Cash
$47.33M
Q1 May 2026
Total Debt
$24.28M
Q1 May 2026
Shares Outstanding
203.07M sh
Q1 May 2026